COURT-RULING ·Filed Mar 30, 2026
Court ruling (district)
Actionable Insight • Neutral
Monitor for subsequent filings or public statements from Moderna regarding the litigation. Given the involvement of Northwestern University, this could relate to intellectual property, but without further details, material impact cannot be assessed.
MRNA drugs
MRNA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60Entry
$48.16
T+0 close · Mar 30, 2026 · via day close
Latest settled
+25.45%
T+60 · $60.42
Vs SPY
+9.43%
α at T+60
Horizons
All settled
through T+60
- T+0 · Mar 30 $48.16entry
- T+1 · 8mo ago +5.40%α +2.51% · $50.76
- T+5 · 7mo ago +3.70%α −0.60% · $49.94
- T+20 · 7mo ago −2.31%α −14.90% · $47.05
- T+60 · 5mo ago +25.45%α +9.43% · $60.42
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable
Court Ruling Details
Court
United States District Court for the District of Delaware
Court Level
District
Case Type
other
Ruling Type
other
Outcome
NULL
Precedent Risk
LOW
Key Facts
- Case: Northwestern University v. Moderna, Inc. et al, filed in U.S. District Court for the District of Delaware
- Date filed: 2026-03-30
- Status: unknown
- Nature of suit or ruling details not available in provided text
Financial Impact
Unknown, no financial figures or ruling details provided
Risk Factors
- Potential IP or patent dispute with academic institution, which could affect future product development if substantiated
- Risk of future financial exposure or injunction if the case proceeds and ruling is adverse
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
10% bullish (30 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-2eno758p-MRNA |
Track record
26 reports on MRNA
6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +14.15% at T+60 after the Mar 5, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $217.29 Now $215.27 −0.93% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 3/10 Entry $222.50 Now $215.27 −3.25% settles Nov 17
- Nov 6, 202610d ago 8-K Bullish 7/10 Entry $254.19 to $269.00 Now $215.27 −15.31% ▲ +5.83% +3.46% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $241.46 to $254.19 Now $215.27 −10.85% ▲ +5.27% +4.96% vs SPY
- Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $214.17 to $222.76 Now $215.27 +0.52% ▲ +4.01% +4.40% vs SPY
- Oct 27, 202620d ago ANALYST-DOWNGRADE Bearish 4/10 Entry $207.97 to $214.17 Now $215.27 −3.51% ▼ −2.98% −2.63% vs SPY
- Sep 30, 20266w ago 8-K Neutral 3/10 Entry $192.57 to $188.94 Now $215.27 +11.79% ▼ −1.89% −2.06% vs SPY
- Sep 30, 20266w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
- Sep 16, 20268w ago Insider Cluster Bearish 5/10 Entry $158.07 to $154.04 Now $215.27 −36.19% ▲ +2.55% +2.43% vs SPY
- Sep 3, 202610w ago ANALYST-DOWNGRADE Bearish 6/10 Entry $148.87 to $145.55 Now $215.27 −44.60% ▲ +2.23% +1.84% vs SPY
Showing 10 of 26
US Market Status
Market Closed · Opens in 6h 24m
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers